Molina Healthcare saw a stunning turnaround last year. Can the growth continue?

Molina Healthcare website
(Molina Healthcare)

Has Molina Healthcare’s new leadership team been so successful in their company turnaround that they’ve run out of places to grow?

Not even close, CEO Joseph Zubretsky said during a presentation at the J.P. Morgan Healthcare Conference this week.

It has been the foremost question facing the company since staging a significant financial comeback over the last year by “harvesting” a number of savings and growth opportunities that took Molina from a net loss of $512 million at the end of 2017 to a net income of $197 million in its third quarter of 2018.

Conference

2019 Drug Pricing and Reimbursement Stakeholder Summit

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape. This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

“In our view, this has been a pretty successful start to a two- to three-year turnaround story,” Zubretsky said. “Yes, there is more.”

RELATED: With a stunning Q2 performance, Molina is officially a comeback story

That includes contracts in Mississippi, Illinois, Idaho, Florida, Ohio, Washington, Utah, Wisconsin and Puerto Rico.

Those revenue opportunities include reentry into Utah and Wisconsin’s state Affordable Care Act marketplaces. Zubretsky told investors last quarter the marketplace “has outperformed our expectations” and signaled a willingness to expand into new states in 2020.

Zubretsky also said more partnerships are in the works with “world-class vendors” focusing on high acuity management, pharmaceuticals and outsourcing IT operations. For example, he said Molina recently renewed a three-year agreement with CVS Caremark. Molina also assembled a consortium of software partners to address payment integrity and expects to announce the consortium over the next month.

Previously, Zubretsky has credited the financial about-face to the insurer's focus on re-contracting with high-cost providers and improving utilization controls that have reduced hospital admissions, ER visits and length of stay. Molina has also beefed up its claims integrity program and slimmed down administrative costs.

In October, Molina Healthcare closed the $231 million sale of its Medicaid management solution to DXC Technology with plans to reinvest the money as it continues its financial rebound.

Suggested Articles

Inmediata Health Group, a healthcare clearinghouse, notified patients last month that their personal health data was potentially exposed due to a misconfigured…

Health insurers’ financial performance is on a continuing upward trend, but political and legal risks could pose a threat to that growth.

Senate lawmakers released a draft package of legislation aimed at curbing healthcare costs they believe they can pass on a bipartisan basis.